Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Paul Drew to Animals

This is a "connection" page, showing publications Paul Drew has written about Animals.

 
Connection Strength
  
 
 
1.604
  
  1. Drew PD. Targeting the Nlrp3 inflammasome as potential treatment for ethanol-induced non-communicable diseases. Am J Drug Alcohol Abuse. 2024 Mar 03; 50(2):125-127.
    View in: PubMed
    Score: 0.081
  2. Holloway KN, Douglas JC, Rafferty TM, Kane CJM, Drew PD. Ethanol Induces Neuroinflammation in a Chronic Plus Binge Mouse Model of Alcohol Use Disorder via TLR4 and MyD88-Dependent Signaling. Cells. 2023 08 21; 12(16).
    View in: PubMed
    Score: 0.078
  3. Holloway KN, Pinson MR, Douglas JC, Rafferty TM, Kane CJM, Miranda RC, Drew PD. Cerebellar Transcriptomic Analysis in a Chronic plus Binge Mouse Model of Alcohol Use Disorder Demonstrates Ethanol-Induced Neuroinflammation and Altered Glial Gene Expression. Cells. 2023 02 25; 12(5).
    View in: PubMed
    Score: 0.075
  4. Niedzwiedz-Massey VM, Douglas JC, Rafferty T, Johnson JW, Holloway KN, Berquist MD, Kane CJM, Drew PD. Effects of chronic and binge ethanol administration on mouse cerebellar and hippocampal neuroinflammation. Am J Drug Alcohol Abuse. 2023 05 04; 49(3):345-358.
    View in: PubMed
    Score: 0.074
  5. Niedzwiedz-Massey VM, Douglas JC, Rafferty T, Kane CJM, Drew PD. Ethanol effects on cerebellar myelination in a postnatal mouse model of fetal alcohol spectrum disorders. Alcohol. 2021 11; 96:43-53.
    View in: PubMed
    Score: 0.067
  6. Niedzwiedz-Massey VM, Douglas JC, Rafferty T, Wight PA, Kane CJM, Drew PD. Ethanol modulation of hippocampal neuroinflammation, myelination, and neurodevelopment in a postnatal mouse model of fetal alcohol spectrum disorders. Neurotoxicol Teratol. 2021 Sep-Oct; 87:107015.
    View in: PubMed
    Score: 0.067
  7. Pinson MR, Holloway KN, Douglas JC, Kane CJM, Miranda RC, Drew PD. Divergent and overlapping hippocampal and cerebellar transcriptome responses following developmental ethanol exposure during the secondary neurogenic period. Alcohol Clin Exp Res. 2021 07; 45(7):1408-1423.
    View in: PubMed
    Score: 0.067
  8. Kane CJM, Douglas JC, Rafferty T, Johnson JW, Niedzwiedz-Massey VM, Phelan KD, Majewska AK, Drew PD. Ethanol modulation of cerebellar neuroinflammation in a postnatal mouse model of fetal alcohol spectrum disorders. J Neurosci Res. 2021 08; 99(8):1986-2007.
    View in: PubMed
    Score: 0.065
  9. Kane CJM, Drew PD. Neuroinflammatory contribution of microglia and astrocytes in fetal alcohol spectrum disorders. J Neurosci Res. 2021 08; 99(8):1973-1985.
    View in: PubMed
    Score: 0.063
  10. Kane CJ, Drew PD. Inflammatory responses to alcohol in the CNS: nuclear receptors as potential therapeutics for alcohol-induced neuropathologies. J Leukoc Biol. 2016 11; 100(5):951-959.
    View in: PubMed
    Score: 0.048
  11. Drew PD, Johnson JW, Douglas JC, Phelan KD, Kane CJ. Pioglitazone blocks ethanol induction of microglial activation and immune responses in the hippocampus, cerebellum, and cerebral cortex in a mouse model of fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2015 Mar; 39(3):445-54.
    View in: PubMed
    Score: 0.043
  12. Drew PD, Kane CJ. Fetal alcohol spectrum disorders and neuroimmune changes. Int Rev Neurobiol. 2014; 118:41-80.
    View in: PubMed
    Score: 0.040
  13. Kane CJ, Phelan KD, Douglas JC, Wagoner G, Johnson JW, Xu J, Phelan PS, Drew PD. Effects of ethanol on immune response in the brain: region-specific changes in adolescent versus adult mice. Alcohol Clin Exp Res. 2014 Feb; 38(2):384-91.
    View in: PubMed
    Score: 0.039
  14. Kane CJ, Phelan KD, Douglas JC, Wagoner G, Johnson JW, Xu J, Drew PD. Effects of ethanol on immune response in the brain: region-specific changes in aged mice. J Neuroinflammation. 2013 May 23; 10:66.
    View in: PubMed
    Score: 0.038
  15. Xu J, Wagoner G, Douglas JC, Drew PD. ?-Lapachone ameliorization of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2013 Jan 15; 254(1-2):46-54.
    View in: PubMed
    Score: 0.036
  16. Kane CJ, Phelan KD, Drew PD. Neuroimmune mechanisms in fetal alcohol spectrum disorder. Dev Neurobiol. 2012 Oct; 72(10):1302-16.
    View in: PubMed
    Score: 0.036
  17. Burns SA, Lee Archer R, Chavis JA, Tull CA, Hensley LL, Drew PD. Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis. Brain Res. 2012 Sep 14; 1473:236-41.
    View in: PubMed
    Score: 0.036
  18. Kane CJ, Phelan KD, Han L, Smith RR, Xie J, Douglas JC, Drew PD. Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-? agonists. Brain Behav Immun. 2011 Jun; 25 Suppl 1:S137-45.
    View in: PubMed
    Score: 0.033
  19. Xu J, Wagoner G, Douglas JC, Drew PD. Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity. J Leukoc Biol. 2009 Aug; 86(2):401-9.
    View in: PubMed
    Score: 0.029
  20. Racke MK, Drew PD. Toll-like receptors in multiple sclerosis. Curr Top Microbiol Immunol. 2009; 336:155-68.
    View in: PubMed
    Score: 0.028
  21. Xu J, Racke MK, Drew PD. Peroxisome proliferator-activated receptor-alpha agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis. J Neurochem. 2007 Dec; 103(5):1801-10.
    View in: PubMed
    Score: 0.026
  22. Xu J, Drew PD. Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia. J Immunol. 2007 Feb 01; 178(3):1904-13.
    View in: PubMed
    Score: 0.025
  23. Zhang-Gandhi CX, Drew PD. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. J Neuroimmunol. 2007 Feb; 183(1-2):50-9.
    View in: PubMed
    Score: 0.024
  24. Xu J, Chavis JA, Racke MK, Drew PD. Peroxisome proliferator-activated receptor-alpha and retinoid X receptor agonists inhibit inflammatory responses of astrocytes. J Neuroimmunol. 2006 Jul; 176(1-2):95-105.
    View in: PubMed
    Score: 0.024
  25. Drew PD, Xu J, Storer PD, Chavis JA, Racke MK. Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders. Neurochem Int. 2006 Jul; 49(2):183-9.
    View in: PubMed
    Score: 0.024
  26. Xu J, Drew PD. 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. J Neuroimmunol. 2006 Feb; 171(1-2):135-44.
    View in: PubMed
    Score: 0.023
  27. Xu J, Storer PD, Chavis JA, Racke MK, Drew PD. Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia. J Neurosci Res. 2005 Aug 01; 81(3):403-11.
    View in: PubMed
    Score: 0.022
  28. Storer PD, Xu J, Chavis JA, Drew PD. Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis. J Neurosci Res. 2005 Apr 01; 80(1):66-74.
    View in: PubMed
    Score: 0.022
  29. Storer PD, Xu J, Chavis J, Drew PD. Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. J Neuroimmunol. 2005 Apr; 161(1-2):113-22.
    View in: PubMed
    Score: 0.022
  30. Drew PD, Storer PD, Xu J, Chavis JA. Hormone regulation of microglial cell activation: relevance to multiple sclerosis. Brain Res Brain Res Rev. 2005 Apr; 48(2):322-7.
    View in: PubMed
    Score: 0.021
  31. Cealie MY, Douglas JC, Swan HK, Vonkaenel ED, McCall MN, Drew PD, Majewska AK. Developmental Ethanol Exposure Impacts Purkinje Cells but Not Microglia in the Young Adult Cerebellum. Cells. 2024 Feb 23; 13(5).
    View in: PubMed
    Score: 0.020
  32. Drew PD, Chavis JA, Bhatt R. Sex steroid regulation of microglial cell activation: relevance to multiple sclerosis. Ann N Y Acad Sci. 2003 Dec; 1007:329-34.
    View in: PubMed
    Score: 0.020
  33. Kielian T, Drew PD. Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation. J Neurosci Res. 2003 Feb 01; 71(3):315-25.
    View in: PubMed
    Score: 0.019
  34. Drew PD, Chavis JA. The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells. J Neuroimmunol. 2001 Apr 02; 115(1-2):28-35.
    View in: PubMed
    Score: 0.016
  35. Lowery RL, Cealie MY, Lamantia CE, Mendes MS, Drew PD, Majewska AK. Microglia and astrocytes show limited, acute alterations in morphology and protein expression following a single developmental alcohol exposure. J Neurosci Res. 2021 08; 99(8):2008-2025.
    View in: PubMed
    Score: 0.016
  36. Barger SW, Chavis JA, Drew PD. Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. J Neurosci Res. 2000 Nov 15; 62(4):503-9.
    View in: PubMed
    Score: 0.016
  37. Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation. J Neuroimmunol. 2000 Nov 01; 111(1-2):77-85.
    View in: PubMed
    Score: 0.016
  38. Drew PD, Chavis JA. Inhibition of microglial cell activation by cortisol. Brain Res Bull. 2000 Jul 15; 52(5):391-6.
    View in: PubMed
    Score: 0.016
  39. Chang JY, Chavis JA, Liu LZ, Drew PD. Cholesterol oxides induce programmed cell death in microglial cells. Biochem Biophys Res Commun. 1998 Aug 28; 249(3):817-21.
    View in: PubMed
    Score: 0.014
  40. Drew PD, Gado AM, Canning RD, Nagle JW, Dehejia AM, Polymeropoulos MH, Biddison WE, Jacobson S, Becker KG. C2H2-546: a zinc finger protein differentially expressed in HTLV-1 infected T cells. J Neurovirol. 1997 Dec; 3(6):455-9.
    View in: PubMed
    Score: 0.013
  41. Chen J, Martindale JL, Cramer C, Gorospe M, Atasoy U, Drew PD, Yu S. The RNA-binding protein HuR contributes to neuroinflammation by promoting C-C chemokine receptor 6 (CCR6) expression on Th17 cells. J Biol Chem. 2017 09 01; 292(35):14532-14543.
    View in: PubMed
    Score: 0.013
  42. Becker KG, Canning RD, Nagle JW, Dehejia AM, Polymeropoulos MH, Lee IJ, Gado AM, Biddison WE, Drew PD. Molecular cloning and mapping of a novel developmentally regulated human C2H2-type zinc finger. Mamm Genome. 1997 Apr; 8(4):287-9.
    View in: PubMed
    Score: 0.012
  43. Cippitelli A, Domi E, Ubaldi M, Douglas JC, Li HW, Demopulos G, Gaitanaris G, Roberto M, Drew PD, Kane CJM, Ciccocioppo R. Protection against alcohol-induced neuronal and cognitive damage by the PPAR? receptor agonist pioglitazone. Brain Behav Immun. 2017 Aug; 64:320-329.
    View in: PubMed
    Score: 0.012
  44. Drew PD, Nagle JW, Canning RD, Ozato K, Biddison WE, Becker KG. Cloning and expression analysis of a human cDNA homologous to Xenopus TFIIIA. Gene. 1995 Jul 04; 159(2):215-8.
    View in: PubMed
    Score: 0.011
  45. Odle AK, Drew PD, Childs GV. Giant mice reveal new roles for GH in regulating the adipose immune microenvironment. Endocrinology. 2015 May; 156(5):1613-5.
    View in: PubMed
    Score: 0.011
  46. Xie L, Chen J, McMickle A, Awar N, Nady S, Sredni B, Drew PD, Yu S. The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2014 Aug 15; 273(1-2):31-41.
    View in: PubMed
    Score: 0.010
  47. Wight RD, Tull CA, Deel MW, Stroope BL, Eubanks AG, Chavis JA, Drew PD, Hensley LL. Resveratrol effects on astrocyte function: relevance to neurodegenerative diseases. Biochem Biophys Res Commun. 2012 Sep 14; 426(1):112-5.
    View in: PubMed
    Score: 0.009
  48. Solt LA, Kumar N, Nuhant P, Wang Y, Lauer JL, Liu J, Istrate MA, Kamenecka TM, Roush WR, Vidovic D, Sch?rer SC, Xu J, Wagoner G, Drew PD, Griffin PR, Burris TP. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature. 2011 Apr 28; 472(7344):491-4.
    View in: PubMed
    Score: 0.008
  49. Drew PD, Ades IZ. Induction of cytochrome P-450 RNA by porphyrogenic agents: on the nature of the coordinate induction with delta-aminolevulinate synthase in tissues of the chicken embryo. Int J Biochem. 1990; 22(6):607-10.
    View in: PubMed
    Score: 0.008
  50. Drew PD, Ades IZ. Regulation of production of delta-aminolaevulinate synthase in tissues of chick embryos. Effects of porphyrogenic agents and of haem precursors. Biochem J. 1989 Sep 15; 262(3):815-21.
    View in: PubMed
    Score: 0.007
  51. Drew PD, Ades IZ. Regulation of the stability of chicken embryo liver delta-aminolevulinate synthase mRNA by hemin. Biochem Biophys Res Commun. 1989 Jul 14; 162(1):102-7.
    View in: PubMed
    Score: 0.007
  52. Gocke AR, Hussain RZ, Yang Y, Peng H, Weiner J, Ben LH, Drew PD, Stuve O, Lovett-Racke AE, Racke MK. Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease. J Immunol. 2009 Apr 01; 182(7):4479-87.
    View in: PubMed
    Score: 0.007
  53. Kielian T, Syed MM, Liu S, Phulwani NK, Phillips N, Wagoner G, Drew PD, Esen N. The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses. J Immunol. 2008 Apr 01; 180(7):5004-16.
    View in: PubMed
    Score: 0.007
  54. Ades IZ, Stevens TM, Drew PD. Biogenesis of embryonic chick liver delta-aminolevulinate synthase: regulation of the level of mRNA by hemin. Arch Biochem Biophys. 1987 Mar; 253(2):297-304.
    View in: PubMed
    Score: 0.006
  55. Drew PD, Ades IZ. Regulation of production of embryonic chick liver delta-aminolevulinate synthase: effects of testosterone and of hemin on the mRNA of the enzyme. Biochem Biophys Res Commun. 1986 Oct 15; 140(1):81-7.
    View in: PubMed
    Score: 0.006
  56. Kielian T, McMahon M, Bearden ED, Baldwin AC, Drew PD, Esen N. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). J Neurochem. 2004 Sep; 90(5):1163-72.
    View in: PubMed
    Score: 0.005
  57. Lovett-Racke AE, Hussain RZ, Northrop S, Choy J, Rocchini A, Matthes L, Chavis JA, Diab A, Drew PD, Racke MK. Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. J Immunol. 2004 May 01; 172(9):5790-8.
    View in: PubMed
    Score: 0.005
  58. Diab A, Hussain RZ, Lovett-Racke AE, Chavis JA, Drew PD, Racke MK. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. J Neuroimmunol. 2004 Mar; 148(1-2):116-26.
    View in: PubMed
    Score: 0.005
  59. Diab A, Deng C, Smith JD, Hussain RZ, Phanavanh B, Lovett-Racke AE, Drew PD, Racke MK. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. J Immunol. 2002 Mar 01; 168(5):2508-15.
    View in: PubMed
    Score: 0.004
  60. Dienel GA, Popp D, Drew PD, Ball K, Krisht A, Cruz NF. Preferential labeling of glial and meningial brain tumors with [2-(14)C]acetate. J Nucl Med. 2001 Aug; 42(8):1243-50.
    View in: PubMed
    Score: 0.004
  61. Lonergan M, Dey A, Becker KG, Drew PD, Ozato K. A regulatory element in the beta 2-microglobulin promoter identified by in vivo footprinting. Mol Cell Biol. 1993 Nov; 13(11):6629-39.
    View in: PubMed
    Score: 0.002
  62. Segars JH, Nagata T, Bours V, Medin JA, Franzoso G, Blanco JC, Drew PD, Becker KG, An J, Tang T, et al. Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65) and retinoic acid receptor beta-retinoid X receptor beta heterodimers. Mol Cell Biol. 1993 Oct; 13(10):6157-69.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.